BOOM

Trending Searches

    SUPPORT
    BOOM

    Trending News

      • Fact Check 
        • Fast Check
        • Politics
        • Business
        • Entertainment
        • Social
        • Sports
        • World
      • Law
      • Explainers
      • News 
        • All News
      • Decode 
        • Impact
        • Scamcheck
        • Life
        • Voices
      • Media Buddhi 
        • Digital Buddhi
        • Senior Citizens
        • Videos
      • Web Stories
      • BOOM Research
      • BOOM Labs
      • Deepfake Tracker
      • Videos 
        • Facts Neeti
      • Home-icon
        Home
      • About Us-icon
        About Us
      • Authors-icon
        Authors
      • Team-icon
        Team
      • Careers-icon
        Careers
      • Internship-icon
        Internship
      • Contact Us-icon
        Contact Us
      • Methodology-icon
        Methodology
      • Correction Policy-icon
        Correction Policy
      • Non-Partnership Policy-icon
        Non-Partnership Policy
      • Cookie Policy-icon
        Cookie Policy
      • Grievance Redressal-icon
        Grievance Redressal
      • Republishing Guidelines-icon
        Republishing Guidelines
      • Fact Check-icon
        Fact Check
        Fast Check
        Politics
        Business
        Entertainment
        Social
        Sports
        World
      • Law-icon
        Law
      • Explainers-icon
        Explainers
      • News-icon
        News
        All News
      • Decode-icon
        Decode
        Impact
        Scamcheck
        Life
        Voices
      • Media Buddhi-icon
        Media Buddhi
        Digital Buddhi
        Senior Citizens
        Videos
      • Web Stories-icon
        Web Stories
      • BOOM Research-icon
        BOOM Research
      • BOOM Labs-icon
        BOOM Labs
      • Deepfake Tracker-icon
        Deepfake Tracker
      • Videos-icon
        Videos
        Facts Neeti
      Trending Tags
      TRENDING
      • #Operation Sindoor
      • #Pahalgam Terror Attack
      • #Narendra Modi
      • #Rahul Gandhi
      • #Waqf Amendment Bill
      • #Arvind Kejriwal
      • #Deepfake
      • #Artificial Intelligence
      • Home
      • Coronavirus
      • AYUSH Ministry Asks Patanjali To...
      Coronavirus

      AYUSH Ministry Asks Patanjali To Stop Advertising COVID-19 Tablets

      Patanjali has claimed its Coronil and Swasari Vati tablets could cure COVID-19 in 3-14 days

      By - Shachi Sutaria |
      Published -  23 Jun 2020 8:57 PM IST
    • Boomlive
      AYUSH Ministry Asks Patanjali To Stop Advertising COVID-19 Tablets

      India's Ministry of AYUSH has asked yoga guru Ramdev's Patanjali Ayurved to stop advertising 'Coronil' and 'Swasari Vati' tablets as cures for COVID-19 and has asked the company to provide more details on the same.

      The ministry also said it did not know the facts about the claim and details of the scientific study Patanjali said it conducted.

      However, it is not clear whether the sale of these ayurvedic medicines can continue.

      The AYUSH (Ayurveda, Yoga, Unani, Sidha, Homeopathy) ministry has ordered Patanjali Ayurved in Uttrakhand to stop advertising and publicising claims of the drugs being a cure for COVID-19. Patanjali also needs to provide the name and composition of the medicines being claimed as COVID treatment along with the site(s)/hospital(s) where the research study was conducted for COVID-19.

      On June 23, 2020, Baba Ramdev launched these medicines and claimed that these clinically tested medicines were cures for the ongoing COVID-19 pandemic. He further claimed that these results showed 100 per cent recovery rate among patients.

      The ministry said it told Patanjali that the advertisement and press conference falls under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules and under the purview of the central government. Any research studies about AYUSH interventions and medicines on COVID-19 also have to be communicated to the ministry, according to a gazette notification issued in April.

      The methodology and protocol, sample size selection, as well as the Institutional Ethics Committee clearance, the Clinical Trial Registry of India (CTRI) registration and resulting data of the said study also needs to be provided to the ministry. The ministry has also asked the State Licensing Authority of Uttarakhand Government to provide copies of the said license and the details of product approval to the centre.

      Patanjali's COVID-19 Ayurvedic Medicines

      Baba Ramdev and Acharya Balkrishna, the CEO of Patanjali launched their COVID-19 Ayurvedic medicines 'Coronil' and 'Swasari Vati' on June 23, 2020 in a press conference. This coronil kit is priced at Rs.545 and would be available in Patanjali stores in a week's time, according to Ramdev. These medicines would be available online on an application in the same time period.

      We've prepared the first Ayurvedic-clinically controlled, research, evidence & trial based medicine for COVID19. We conducted a clinical case study&clinical controlled trial, and found 69% patients recovered in 3 days & 100% patients recovered in 7 days: Yog Guru Ramdev, Haridwar pic.twitter.com/QFQSVF0JIh

      — ANI (@ANI) June 23, 2020

      Ramdev claimed that the medicines are not an immunity booster but a cure for COVID-19 and have showed 100 per cent favourable results during clinical trials on affected patients at the Patanjali Yogapeeth in Haridwar. They, however, did not include people older than 60, who had respiratory disorders, and who were severely symptomatic.

      Balkrishna claimed that their medicines cured the disease in 3-14 days while Ramdev claimed that 69% of the patients recovered in three days. Patanjali also stated that they were assisted in this endeavour by the National Institute of Medical Sciences, Jaipur.

      Balkrishna had stated earlier this month that the company was conducting tests and was going to come out with the first Ayurvedic COVID-19 medicine.


      Tags

      AYUSHPatanjalibaba ramdevacharya balkrishnanimscoronilswasari vatiCOVID-19
      Read Full Article
      Next Story
      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker. Please reload after ad blocker is disabled.
      X

      Subscribe to BOOM Newsletters

      👉 No spam, no paywall — but verified insights.

      Please enter a Email Address
      Subscribe for free!

      Stay Ahead of Misinformation!

      Please enter a Email Address
      Subscribe Now🛡️ 100% Privacy Protected | No Spam, Just Facts
      By subscribing, you agree with the Terms & conditions and Privacy Policy connected to the offer

      Thank you for subscribing!

      You’re now part of the BOOM community.

      Or, Subscribe to receive latest news via email
      Subscribed Successfully...
      Copy HTMLHTML is copied!
      There's no data to copy!